146 related articles for article (PubMed ID: 8163586)
21. SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154.
Innis R; Zoghbi S; Johnson E; Woods S; al-Tikriti M; Baldwin R; Seibyl J; Malison R; Zubal G; Charney D
Eur J Pharmacol; 1991 Feb; 193(2):249-52. PubMed ID: 1646734
[TBL] [Abstract][Full Text] [Related]
22. Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans.
Onishi Y; Yonekura Y; Mukai T; Nishizawa S; Tanaka F; Okazawa H; Ishizu K; Fujita T; Shibasaki H; Konishi J
J Nucl Med; 1995 Jul; 36(7):1201-10. PubMed ID: 7790945
[TBL] [Abstract][Full Text] [Related]
23. Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time.
Onishi Y; Yonekura Y; Tanaka F; Nishizawa S; Okazawa H; Ishizu K; Fujita T; Konishi J; Mukai T
Eur J Nucl Med; 1996 Nov; 23(11):1491-7. PubMed ID: 8854848
[TBL] [Abstract][Full Text] [Related]
24. Quantification of GABAA receptors in the rat brain with [(123)I]Iomazenil SPECT from factor analysis-denoised images.
Tsartsalis S; Moulin-Sallanon M; Dumas N; Tournier BB; Ghezzi C; Charnay Y; Ginovart N; Millet P
Nucl Med Biol; 2014 Feb; 41(2):186-95. PubMed ID: 24405841
[TBL] [Abstract][Full Text] [Related]
25. Maturational Changes of Gamma-Aminobutyric Acid A Receptors Measured With Benzodiazepine Binding of Iodine 123 Iomazenil Single-Photon Emission Computed Tomography.
Ikemoto S; Hamano SI; Hirata Y; Matsuura R; Kikuchi K
Pediatr Neurol; 2018 May; 82():19-24. PubMed ID: 29625846
[TBL] [Abstract][Full Text] [Related]
26. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.
Price JC; Mayberg HS; Dannals RF; Wilson AA; Ravert HT; Sadzot B; Rattner Z; Kimball A; Feldman MA; Frost JJ
J Cereb Blood Flow Metab; 1993 Jul; 13(4):656-67. PubMed ID: 8391018
[TBL] [Abstract][Full Text] [Related]
27. [Results of displacement studies on benzodiazepine receptors (123I-iomazenil and flumazenil)].
Buchali K
Nuklearmedizin; 1992 Feb; 31(1):29-31. PubMed ID: 1313973
[TBL] [Abstract][Full Text] [Related]
28. Alterations of benzodiazepine receptor binding potential in anxiety and somatoform disorders measured by 123I-iomazenil SPECT.
Tokunaga M; Ida I; Higuchi T; Mikuni M
Radiat Med; 1997; 15(3):163-9. PubMed ID: 9278373
[TBL] [Abstract][Full Text] [Related]
29. In vivo quantification of dopamine D2 receptor parameters in nonhuman primates with [123I]iodobenzofuran and single photon emission computerized tomography.
Laruelle M; al-Tikriti MS; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Charney DS; Hoffer PB; Kung HF; Innis RB
Eur J Pharmacol; 1994 Sep; 263(1-2):39-51. PubMed ID: 7821360
[TBL] [Abstract][Full Text] [Related]
30. [Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT].
Kawabata K; Tachibana H; Sugita M; Fukuchi M
Kaku Igaku; 1996 Apr; 33(4):391-7. PubMed ID: 8683878
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates.
Zoghbi SS; Baldwin RM; Seibyl JP; al-Tikriti MS; Zea-Ponce Y; Laruelle M; Sybirska EH; Woods SW; Goddard AW; Malison RT
Int J Rad Appl Instrum B; 1992 Nov; 19(8):881-8. PubMed ID: 1330992
[TBL] [Abstract][Full Text] [Related]
32. Dual-isotope autoradiographic measurement of regional blood flow and benzodiazepine receptor availability following unilateral middle cerebral artery occlusion.
al-Tikriti MS; Dey HM; Zoghbi SS; Baldwin RM; Zea-Ponce Y; Innis RB
Eur J Nucl Med; 1994 Mar; 21(3):196-202. PubMed ID: 8200386
[TBL] [Abstract][Full Text] [Related]
33. [Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT].
Yonekura Y; Nishizawa S; Tanaka F; Ishizu K; Okazawa H; Fujita T; Konishi J; Torizuka K
Kaku Igaku; 1995 Jan; 32(1):87-97. PubMed ID: 7897872
[TBL] [Abstract][Full Text] [Related]
34. Benzodiazepine receptor distribution in severe intractable tinnitus.
Daftary A; Shulman A; Strashun AM; Gottschalk C; Zoghbi SS; Seibyl JP
Int Tinnitus J; 2004; 10(1):17-23. PubMed ID: 15379343
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive quantification of iodine-123-iomazenil SPECT.
Onishi Y; Yonekura Y; Nishizawa S; Tanaka F; Okazawa H; Ishizu K; Fujita T; Konishi J; Mukai T
J Nucl Med; 1996 Feb; 37(2):374-8. PubMed ID: 8667079
[TBL] [Abstract][Full Text] [Related]
36. Benzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenil.
Videbaek C; Friberg L; Holm S; Wammen S; Foged C; Andersen JV; Dalgaard L; Lassen NA
Eur J Pharmacol; 1993 Nov; 249(1):43-51. PubMed ID: 8282018
[TBL] [Abstract][Full Text] [Related]
37. Decreased benzodiazepine receptor binding in Machado-Joseph disease.
Ishibashi M; Sakai T; Matsuishi T; Yonekura Y; Yamashita Y; Abe T; Ohnishi Y; Hayabuchi N
J Nucl Med; 1998 Sep; 39(9):1518-20. PubMed ID: 9744334
[TBL] [Abstract][Full Text] [Related]
38. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study.
Dong Y; Fukuyama H; Nabatame H; Yamauchi H; Shibasaki H; Yonekura Y
Stroke; 1997 Sep; 28(9):1776-82. PubMed ID: 9303025
[TBL] [Abstract][Full Text] [Related]
39. No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia.
Abi-Dargham A; Laruelle M; Krystal J; D'Souza C; Zoghbi S; Baldwin RM; Seibyl J; Mawlawi O; de Erasquin G; Charney D; Innis RB
Neuropsychopharmacology; 1999 Jun; 20(6):650-61. PubMed ID: 10327433
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic analysis of benzodiazepine receptor binding of [123I]iomazenil in human brain.
Ito K; Momose T; Kotaki H; Kojima Y; Yamamoto K; Katashima M; Sawada Y; Sasaki Y; Iga T
Pharm Res; 1997 Aug; 14(8):999-1003. PubMed ID: 9279879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
